COPD: influenza vaccine reduces the number of exacerbations
|
|
|
Clinical bottom line (level 1a-)
- Patients with COPD who receive influenza vaccine
compared with placebo have fewer exacerbations subsequently
(on average 0.5 fewer).
- The effect on pneumonia and mortality is unclear.
| |
Poole et al: Cochrane Library 2000; 2 : -
|
Expires October 2003 |
The study Systematic review of all randomised controlled trials of
Patients: COPD
Intervention: live or inactivated influenza vaccine compared with
placebo
Outcome: pneumonia, death
Articles found in ?all languages
using Cochrane Airways Group trials register derived from Medline, Embase,
CINAHL, and hand-searches of respiratory journals and meeting abtracts, -
(search terms: detailed in text ) and and searching bibliographies of
retrieved studies for relevant articles. Drug companies and study authors
were contacted to identify unpublished material.
Selection
criteria: see above Appraisal criteria: by 3 independent reviewers
using the Jadad score Articles excluded if:
9 studies found; 4 specifically
performed in 215 patients with COPD; the others involved elderly or
chronically ill patients of whom some had COPD>
The evidence
| Outcome |
Time to outcome |
CER |
OR (95% CI) |
NN T (95% CI) |
| COPD exacerbation |
3 weeks |
27/51 (52.9%) |
1.06 (0.48 to 2.33) |
-69 (NNT = 6 to infinity; NNH = 5 to infinity)
|
- Weighted mean difference total exacerbations per patient: influenza
vaccine v. placebo: - 0.45 (95% CI: -0.75 to -0.15)
Comments
- The studies assessing hospitalisation and death were too small to
exclude important clinical effects.
Citation
- Poole PJ, Chacko E, Wood-Baker RWB: influenza vaccine for patients
with chronic obstructive pulmonary disease. Cochrane Library 2000; 2 : -
Search Terms: COPD in Cochrane Library Contributor: Chris
Ball, October 2001 Reviewer:
Clinical Question.
| Patient |
COPD |
| Intervention or Exposure |
influenza vaccine |
| Comparison |
placebo |
| Outcome |
pneumonia, death | |
|